External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.
Tamura K, Osawa T, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Sugimoto M, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Komiyama M, Tanaka K, Yokomizo A, Kohei N, Shinohara N, Miyake H; Japanese Urological Oncology Group.
Tamura K, et al. Among authors: yokomizo a.
Jpn J Clin Oncol. 2021 Apr 30;51(5):810-818. doi: 10.1093/jjco/hyaa264.
Jpn J Clin Oncol. 2021.
PMID: 33479762